MA Boston의 뇌종양 임상 시험
뇌종양 관련 연구 29개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
피험자 모집 중2상
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
피험자 모집 중2상
- Local Institution - 0124, Boston
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
피험자 모집 중2상
- Massachusetts General Hospital, Boston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
EXercise-induced PhysioLogical Adaptations In Neurological Disorders
피험자 모집 중건강한 지원자 환영
- Brigham and Women's Hospital, Boston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
Supportive Psychoeducational Intervention for Patients With Brain Tumors (Acceptance and Commitment Therapy-based Supportive Intervention for Patients With Central Nervous System Tumors)
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
NeuroPathways Intervention for Brain Tumor Patients
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- Tufts Medical Center, Boston
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
피험자 모집 중
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
피험자 모집 중2상
- Brigham and Women's Hospital / Dana-Farber Cancer Institute, Boston
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
Targeted Pediatric High-Grade Glioma Therapy
피험자 모집 중관찰 연구
- Dana-Farber Cancer Institute, Boston
B7-H3.CD28Z.CART in CNS Neoplasms
피험자 모집 중1상
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of Olutasidenib and Temozolomide in HGG
피험자 모집 중2상
- Susan Chi, Boston
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
피험자 모집 중
- Massachusetts General Hospital, Boston
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
피험자 모집 중관찰 연구
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Palbociclib and Pembrolizumab In Central Nervous System Metastases
피험자 모집 중2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
피험자 모집 중3상
- Tufts Medical Center, Boston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
피험자 모집 중2상
- Dana-Farber Cancer Institute, Boston
NTS-WBRT in Brain Metastases
피험자 모집 중2상
- Massachusetts General Hospital Cancer Center, Boston
Stereotactic Magnetic Resonance Guided Radiation Therapy
피험자 모집 중
- Brigham & Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
피험자 모집 중초기 1상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
피험자 모집 중1/2상
- Beth Israel Deaconess Medical Center, Boston
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
다른 도시의 뇌종양 시험
- Houston, TX연구 37개
- New York City, NY연구 25개
- Washington, DC연구 21개
- Los Angeles, CA연구 17개
- Durham, NC연구 15개
- Miami, FL연구 14개
- Chicago, IL연구 12개
- Rochester, MN연구 12개
- St. Louis, MO연구 12개
- Cleveland, OH연구 11개
- Columbus, OH연구 11개
- Seattle, WA연구 11개
Boston의 다른 연구
- 유방암연구 110개
- 암 (전체)연구 90개
- 비소세포폐암연구 87개
- 폐암연구 63개
- 대장직장암연구 62개
- 난소암연구 62개
- 전이성 암연구 61개
- 전립선암연구 56개
- 자궁내막암연구 51개
- 우울증연구 50개
- 심부전연구 46개
- 다발성 골수종연구 45개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.